Original Research

Published on 16 Jan 2023

Analysis of spontaneous reports of suspected adverse reactions after vaccination against COVID-19 in Slovakia

in Drugs Outcomes Research and Policies

Monika Lassanova
Stefan Lassan
Silvia Liskova
Tomas Tesar
Monika Cicova

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1097890

2,583 views
3 citations

Original Research

Published on 13 Jan 2023

Adverse drug reactions in an ageing PopulaTion (ADAPT) study: Prevalence and risk factors associated with adverse drug reaction-related hospital admissions in older patients

in Drugs Outcomes Research and Policies

Caitriona Cahir
Carmel Curran
Caroline Walsh
Anne Hickey
Ross Brannigan
Ciara Kirke
David J. Williams
Kathleen Bennett

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1029067

6,017 views
13 citations

Perspective

Published on 12 Jan 2023

Advancing evidence-based treatment of infectious diseases in children with real-world data: Opportunities and challenges

in Drugs Outcomes Research and Policies

Kendra K. Radtke
Atul J. Butte

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1054688

1,884 views
1 citation

Original Research

Published on 12 Jan 2023

Treatment attrition rates and relevant risk factors in multiple myeloma: A real-world study in China

in Drugs Outcomes Research and Policies

Wenjiao Tang
Jinrong Yang
Yan Li
Li Zhang
He Li
Jie Wang
Yi Liao
Chunlan Zhang
Ying Qu
Yuhuan Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.979111

3,045 views
2 citations

Correction

Published on 11 Jan 2023

Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy

in Drugs Outcomes Research and Policies

Geeta S. Bhagwat
Rajani B. Athawale
Rajeev P. Gude
Shadab Md
Nabil A. Alhakamy
Usama A. Fahmy
Prashant Kesharwani

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1123542

1,061 views

Systematic Review

Published on 10 Jan 2023

Efficacy and safety of concomitant use of proton pump inhibitors with aspirin-clopidogrel dual antiplatelet therapy in coronary heart disease: A systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Xiaofeng Luo
Min Hou
Shuangshuang He
Xue Yang
Pan Zhang
Yingxin Zhao
Haiyan Xing

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1021584

6,839 views
5 citations

Clinical Trial

Published on 10 Jan 2023

Investigation of drug-related problems in patients hospitalized in chest disease wards: A randomized controlled trial

in Drugs Outcomes Research and Policies

Muhammed Yunus Bektay
Mesut Sancar
Fatmanur Okyaltirik
Bulent Durdu
Fikret Vehbi Izzettin

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1049289

2,284 views
5 citations

Original Research

Published on 10 Jan 2023

Clinical outcomes of dose modification during pirfenidone treatment for IPF: A nationwide post-marketing surveillance study

in Drugs Outcomes Research and Policies

Jieun Kang
Man Pyo Chung
Moo Suk Park
In Jae Oh
Heung Bum Lee
Young Whan Kim
Jong Sun Park
Soo Taek Uh
Yun Seong Kim
Yangjin Jegal

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1025947

3,069 views
6 citations

Original Research

Published on 09 Jan 2023

Clinical effectiveness of sodium bicarbonate therapy on mortality for septic patients with acute moderate lactic acidosis

in Drugs Outcomes Research and Policies

Sai Huang
Bo Yang
Yaojun Peng
Qinrui Xing
Lili Wang
Jing Wang
Xuan Zhou
Yuan Yao
Li Chen
Cong Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1059285

4,095 views
1 citation

Review

Published on 09 Jan 2023

Immune-mediated hepatitis induced by immune checkpoint inhibitors: Current updates and future perspectives

in Drugs Outcomes Research and Policies

Zherui Liu
Yun Zhu
Huan Xie
Zhengsheng Zou

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1077468

11,195 views
25 citations

Editorial

Published on 09 Jan 2023

Editorial: Medication safety and interventions to reduce patient harm in low- and middle-income countries

in Drugs Outcomes Research and Policies

Mansour Adam Mahmoud
Johanna C. Meyer
Ahmed Awaisu
Joseph Fadare
Ahmed Ibrahim Fathelrahman
Fahad Saleem
Hisham Aljadhey
Brian Godman

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1124371

1,512 views

Original Research

Published on 04 Jan 2023

The importance of reminders and patient preferences to improve inhaler technique in older adults with COPD

in Drugs Outcomes Research and Policies

P. Barnestein-Fonseca
VM. Cotta-Luque
VP. Aguiar-Leiva
J. Leiva-Fernández
Francisco Martos-Crespo
F. Leiva-Fernández

Frontiers in Pharmacology

doi 10.3389/fphar.2022.989362

2,665 views
4 citations

Original Research

Published on 04 Jan 2023

Cost-effectiveness of fuzuloparib compared to routine surveillance, niraparib and olaparib for maintenance treatment of patients with germline BRCA1/2 mutation and platinum-sensitive recurrent ovarian carcinoma in China

in Drugs Outcomes Research and Policies

Jing Nie
Huina Wu
Lei Sun
Yanjiao Ding
Yepeng Luan
Jiyong Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.987337

2,245 views
7 citations

Systematic Review

Published on 23 Dec 2022

Treatment for chemotherapy-induced peripheral neuropathy: A systematic review of randomized control trials

in Drugs Outcomes Research and Policies

Chenkun Wang
Si Chen
Weiwei Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1080888

9,332 views
7 citations

Original Research

Published on 23 Dec 2022

Attitudes and behaviors regarding online pharmacies in the aftermath of COVID-19 pandemic: At the tipping point towards the new normal

in Drugs Outcomes Research and Policies

András Fittler
Tünde Ambrus
Anna Serefko
Lenka Smejkalová
Anna Kijewska
Aleksandra Szopa
Mátyás Káplár

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1070473

13,078 views
23 citations

Original Research

Published on 22 Dec 2022

Flecainide and risk of skin neoplasms: Results of a large nested case–control study in Spain and Denmark

in Drugs Outcomes Research and Policies

Carlen Reyes
Luz M León-Muñoz
Andrea Pistillo
Sigrún Alba Jóhannesdóttir Schmidt
Kasper Bruun Kristensen
Diana Puente
Ana LLorente-García
Consuelo Huerta-Álvarez
Anton Pottegård
Talita Duarte-Salles

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1002451

1,857 views

Navigation group

Articles

Analysis of spontaneous reports of suspected adverse reactions after vaccination against COVID-19 in Slovakia

Adverse drug reactions in an ageing PopulaTion (ADAPT) study: Prevalence and risk factors associated with adverse drug reaction-related hospital admissions in older patients

Advancing evidence-based treatment of infectious diseases in children with real-world data: Opportunities and challenges

Treatment attrition rates and relevant risk factors in multiple myeloma: A real-world study in China

Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy

Efficacy and safety of concomitant use of proton pump inhibitors with aspirin-clopidogrel dual antiplatelet therapy in coronary heart disease: A systematic review and meta-analysis

Investigation of drug-related problems in patients hospitalized in chest disease wards: A randomized controlled trial

Clinical outcomes of dose modification during pirfenidone treatment for IPF: A nationwide post-marketing surveillance study

Clinical effectiveness of sodium bicarbonate therapy on mortality for septic patients with acute moderate lactic acidosis

Immune-mediated hepatitis induced by immune checkpoint inhibitors: Current updates and future perspectives

Editorial: Medication safety and interventions to reduce patient harm in low- and middle-income countries

The importance of reminders and patient preferences to improve inhaler technique in older adults with COPD

Cost-effectiveness of fuzuloparib compared to routine surveillance, niraparib and olaparib for maintenance treatment of patients with germline BRCA1/2 mutation and platinum-sensitive recurrent ovarian carcinoma in China

Treatment for chemotherapy-induced peripheral neuropathy: A systematic review of randomized control trials

Attitudes and behaviors regarding online pharmacies in the aftermath of COVID-19 pandemic: At the tipping point towards the new normal

Flecainide and risk of skin neoplasms: Results of a large nested case–control study in Spain and Denmark